Genomic and Epigenomic Profiling Market Development Driven by Investment in Biotechnology Research and Genomic Screening Programs

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Genomic & Epigenomic Profiling Market Size, Share & Trends Analysis Report, By Type (Genomic Profiling and Epigenomic Profiling), By Application (Clinical Diagnostics, Agriculture & Animal Research, and Drug Discovery & Development), By Technology (NGS, PCR-based, and Microarray), By End-use (Hospitals, Pharmaceuticals, and Research Institutes),-Market Outlook And Industry Analysis 2034"

Genomic & Epigenomic Profiling Market Size is valued at US$ 5.5 Bn in 2024 and is predicted to reach US$ 23.2 Bn by the year 2034 at an 15.8% CAGR during the forecast period for 2025-2034.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/3271

Genomic and epigenomic profiling represent sophisticated analytical approaches for investigating the genetic and regulatory architecture of cellular systems. Genomic profiling enables the detection of single-nucleotide variants, insertions and deletions, copy-number variations, and structural rearrangements through techniques such as whole-genome sequencing, targeted sequencing, and genotyping arrays.

Epigenomic profiling, on the other hand, assesses chemical and structural modifications that regulate gene expression without altering the DNA sequence itself. The global market for genomic and epigenomic profiling is being propelled by rising prevalence of cancer and rare diseases, continuous technological advancements in sequencing and analytical platforms, and the growing emphasis on personalized medicine. Additionally, sustained investment by pharmaceutical and biotechnology companies in precision therapeutics is expected to further accelerate market expansion over the forecast period.

List of Prominent Players in the Genomic & Epigenomic Profiling Market:
• Illumina
• Thermo Fisher Scientific
• Agilent Technologies
• Bio-Rad Laboratories
• Roche
• Qiagen
• PerkinElmer
• Pacific Biosciences
• BGI Genomics
• New England Biolabs
• Merck KGaA
• Diagenode
• Promega Corporation
• 10x Genomics
• Oxford Nanopore Technologies
• QIAGEN
• Zymo Research
• Fulgent Genetics
• GENEWIZ
• Eurofins Scientific
• Invitae
• Myriad Genetics
• Adaptive Biotechnologies
• Guardant Health
• Invivoscribe
• Others

Read Overview Report- https://www.insightaceanalytic.com/report/genomic-and-epigenomic-profiling-market/3271

Market Dynamics
Drivers:
The global genomic and epigenomic profiling market is being propelled by advancements in high-throughput sequencing technologies, which have enhanced accessibility and significantly reduced costs. The increasing prevalence of complex diseases, including cancer, neurological disorders, and autoimmune conditions, has amplified demand for molecular diagnostics and personalized medicine, driving market growth.

Additionally, substantial investments by pharmaceutical and biotechnology firms in the development of targeted therapeutics are accelerating market expansion. The integration of genomic profiling into clinical trials, augmented government funding, and expanded research initiatives further contribute to the sector's growth trajectory.

Challenges:
Market expansion is challenged by the complexity of managing large-scale genomic and epigenomic datasets, which necessitate advanced computational infrastructure and specialized bioinformatics expertise. Standardizing laboratory protocols and analytical methodologies across diverse platforms remains a significant barrier, potentially affecting data consistency and reliability.

Compliance with evolving data privacy regulations, including GDPR, introduces additional complexity for market participants. Translating epigenomic insights into actionable clinical or therapeutic strategies continues to pose scientific challenges, while regulatory uncertainties surrounding novel assays may delay approvals and reimbursement, constraining overall market growth.

Regional Trends:
In 2024, North America dominated the genomic and epigenomic profiling market, driven by a well-established healthcare infrastructure, substantial research and development expenditure, and broad access to cutting-edge technologies. The high prevalence of chronic diseases, including cancer, cardiovascular disorders, and neurological conditions, has further reinforced demand for precision medicine solutions. Genomic and epigenomic profiling is instrumental in enabling patient-specific treatment strategies through detailed genetic insights.

The Asia-Pacific region is projected to achieve the fastest growth over the forecast period, supported by rising healthcare expenditures, increasing awareness of precision medicine, and favorable government initiatives. Countries such as China, Japan, South Korea, and India are investing heavily in genomic research, infrastructure development, and workforce training. Moreover, population-scale genetic screening programs and enhanced access to advanced diagnostic technologies are expected to stimulate innovation and drive sustained market expansion in the region.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customization/3271

Recent Developments:
• November 2024: The Phase I clinical trials for MyCHELANGELTM, an epigenomic controller that targets uncommon disorders, were successfully completed, according to Omega Therapeutics, indicating advancements in therapeutic epigenetic modulation.

Segmentation of Genomic & Epigenomic Profiling Market-
Genomic & Epigenomic Profiling Market- By Type
• Genomic Profiling
• Epigenomic Profiling
Genomic & Epigenomic Profiling Market- By Application
• Clinical Diagnostics
• Agriculture & Animal Research
• Drug Discovery & Development
Genomic & Epigenomic Profiling Market- By Technology
• NGS
• PCR-based
• Microarray
Genomic & Epigenomic Profiling Market- By End-use
• Hospitals
• Pharmaceuticals
• Research Institutes
Genomic & Epigenomic Profiling Market- By Region
North America-
• The US
• Canada
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Mexico
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.